Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about BMY
Recent news which mentions BMY
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Bristol Myers' Breyanzi Immunotherapy Approved In Europe For Lymphoma Indications
April 05, 2022
Tickers
BMY
Tags
Biotech
Briefs
News
From
Benzinga
Bristol Myers Squibb Scores Three Back To Back European Approvals For Opdivo In Esophageal, Urothelial Cancer
April 05, 2022
Tickers
BMY
Tags
Market News
Benzinga
Biotech
From
Benzinga
2 Buffett Stocks That Are Great Buys in April
April 05, 2022
Tickers
AXP
BMY
MA
V
Tags
V
Market News
BMY
From
Motley Fool
The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel
April 05, 2022
Tickers
ACAD
ARGX
ATRA
BMY
Tags
SAGE
News
BTAI
From
Benzinga
7 Biotech Stocks to Buy With Key Catalysts for April
April 05, 2022
Tickers
ABBV
ALNY
AMGN
APTX
Tags
TARS
BPMC
IBB
From
InvestorPlace
Analyzing Bristol-myers Squibb Company's Short Interest
April 04, 2022
Tickers
BMY
Tags
BMY
Benzinga
Short Sellers
From
Benzinga
Bristol Myers' Mavacamten Shows Sustained Improvements In Cardiovascular Outcomes In Cardiomyopathy Study
April 04, 2022
Tickers
BMY
Tags
Benzinga
Market News
General
From
Benzinga
7 No-Brainer Stocks to Buy for April
April 04, 2022
Tickers
BMY
GRMN
INTC
KO
Tags
SWKS
BMY
Stocks to Buy
From
InvestorPlace
The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight
April 03, 2022
Tickers
ACAD
AKBA
AMLX
AMRX
Tags
Biotech
Small Cap
ANGO
From
Benzinga
2 Drugmakers Set for Explosive Revenue This Decade
April 03, 2022
Tickers
ABBV
AZN
BMY
GILD
Tags
OPHLY
JNJ
MRK
From
Motley Fool
Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates
April 01, 2022
Tickers
ABBV
AKBA
ALNY
AMRX
Tags
Market News
SUPN
LLY
From
Benzinga
2 Warren Buffett Stocks to Buy Now and Hold Forever
March 31, 2022
Tickers
BMY
BRK-A
BRK-B
MA
Tags
MA
BMY
Recent Press Releases
From
Motley Fool
Portage Biotech Shares Encouraging Preliminary Safety Data From Lead iNKT Agonists Program In Cancer Patients
March 31, 2022
Tickers
BMY
MRK
PRTG
Tags
Phase 2 Trial
Market News
MRK
From
Benzinga
5 Charts That Show Why Bristol-Myers Squibb Is a No-Brainer Buy
March 30, 2022
Tickers
ABBV
BMY
BNTX
GILD
Tags
OPHLY
JNJ
BMY
From
Motley Fool
How to Buy Digital World Acquisition at Nearly Half the Price
March 30, 2022
Tickers
AAPL
BMY
DWAC
Tags
Trading
BMY
Trading Advice
From
InvestorPlace
2 Stocks Defying the Market Sell-Off Right Now
March 29, 2022
Tickers
BMY
EXEL
Tags
EXEL
Market News
Recent Press Releases
From
Motley Fool
Bristol-Myers Squibb Whale Trades Spotted
March 28, 2022
Tickers
BMY
Tags
BZI/UOA
Markets
Market News
From
Benzinga
Which Chinese Stocks Will Be Delisted? 8 in U.S. Crosshairs
March 28, 2022
Tickers
ACMR
AMGN
BABA
BGNE
Tags
BGNE
AMGN
Hot Stocks
From
InvestorPlace
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
March 27, 2022
Tickers
ADMP
AFIB
AFMD
AGRX
Tags
AKBA
Trading Ideas
AFIB
From
Benzinga
How Pfizer's $6.7 Billion Arena Pharmaceuticals Buyout Could Work for Investors
March 26, 2022
Tickers
BMY
BNTX
PFE
Tags
Market News
BNTX
PFE
From
Motley Fool
Check Out What Whales Are Doing With BMY
March 25, 2022
Tickers
BMY
Tags
Market News
Markets
BZI/UOA
From
Benzinga
FDA Pushes Bristol Myers' Reblozyl Decision Date In Non-Transfusion Dependent Beta Thalassemia
March 25, 2022
Tickers
BMY
Tags
FDA
Benzinga
Market News
From
Benzinga
The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO
March 25, 2022
Tickers
ANTX
ATHA
BMY
CODX
Tags
ZGNX
RHHBY
News
From
Benzinga
Sunshine Biopharma's $8 Million Private Placement Injects New Funding For Drug Development
March 24, 2022
Tickers
BMY
PFE
SB
SBFM
Tags
Biotech
BMY
Market News
From
Benzinga
The Daily Biotech Pulse: Pfizer Reports Positive Ulcerative Colitis Study Data, Novavax COVID Shot Authorized For Adolescents In India, Argenx Stock Sale
March 23, 2022
Tickers
APTO
APTX
ARGX
BMY
Tags
APTX
PFE
Benzinga
From
Benzinga
This Beaten-Down Dividend Stock Is Still a Buy
March 23, 2022
Tickers
ARE
BMY
LLY
MRNA
Tags
BMY
Recent Press Releases
MRNA
From
Motley Fool
This group of stocks is flagging a rebound, and that’s good news for the S&P 500, says technical analyst
March 22, 2022
Tickers
AAPL
AMC
AZN
BABA
Tags
GME
JNJ
DK:NOVO/B
From
MarketWatch
This Is What Whales Are Betting On Bristol-Myers Squibb
March 21, 2022
Tickers
BMY
Tags
BMY
Benzinga
Options
From
Benzinga
Bristol Myers Sues AstraZeneca Over PD-L1 Cancer Drug Patents
March 21, 2022
Tickers
AZN
AZNCF
BMY
Tags
Market News
AZNCF
Benzinga
From
Benzinga
Bristol Myers Squibb Embarks Oncology Pact With Volastra Therapeutics
March 21, 2022
Tickers
BMY
Tags
Market News
Benzinga
Large Cap
From
Benzinga
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.